Safety and Efficacy of AB-1002 Gene Therapy in Patients with Advanced Heart Failure: Results from an Ongoing Phase 1 Clinical Trial

被引：0

作者：

Roberts, Luke ^{[1
]}

Henry, Timothy ^{[2
]}

Chung, Eugene ^{[2
]}

Alvisi, Monica ^{[1
]}

Sethna, Ferzin ^{[1
]}

Murray, David ^{[3
]}

Traverse, Jay ^{[4
]}

Roessig, Lothar ^{[1
]}

Ozkan, Tugba ^{[1
]}

Webb, Stacy ^{[1
]}

Mittal, Monika ^{[1
]}

Ervin, Leigh ^{[1
]}

Walker, Kaitlyn ^{[1
]}

Sadek, Hesham ^{[5
]}

Mikhail, Sheila ^{[1
]}

Haghighi, Kobra ^{[6
]}

Jiang, Canwen ^{[1
]}

Samulski, R. Jude ^{[1
]}

Kranias, Evangelia G. ^{[6
]}

Tretiakova, Anna ^{[1
]}

Hajjar, Roger ^{[7
]}

机构：

[1] Asklepios BioPharmaceut Inc, Durham, NC USA

[2] Christ Hosp, Cincinnati, OH USA

[3] Univ Wisconsin, Madison, WI USA

[4] Minneapolis Heart Inst, Minneapolis, MN USA

[5] UT Southwestern Med Ctr, Dallas, TX USA

[6] Univ Cincinnati, Cincinnati, OH USA

[7] Massachusetts Gen Brigham, Cambridge, MA USA

来源：

MOLECULAR THERAPY | 2024年 / 32卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：5 / 6

页数：2

共 50 条

[1] GenePHIT phase 2 study design: a double blind, placebo-controlled trial to assess efficacy, safety, and tolerability of AB-1002 gene therapy in adults with heart failure
Henry, T.
Chung, E. S.
Alvisi, M.
Sethna, F.
Roessig, L.
Roberts, L.
Reddy, S.
Ervin, L.
Mikhail, S.
Jiang, C.
Samulski, J.
Kranias, E. G.
Tretiakova, A.
Hajjar, R. J.
EUROPEAN HEART JOURNAL, 2024, 45
[2] Safety and efficacy of a phase 1 clinical gene therapy trial in patients with advanced heart failure using a rationally designed cardiotropic AAV vector targeting protein phosphatase inhibitor-1
Henry, T. D.
Chung, E.
Alvisi, M.
Sethna, F.
Murray, D.
Traverse, J. H.
Roberts, L.
Roessig, L.
Ervin, L.
Mikhail, S.
Jiang, C.
Samulski, J.
Kranias, E. G.
Tretiakova, A.
Hajjar, R. J.
EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 237 - 238
[3] Rationally designed cardiotropic AAV2i8.I-1c demonstrates targeted cardiomyocyte distribution and a promising safety and efficacy profile in an ongoing phase 1 clinical gene therapy trial in patients with advanced heart failure
Alvisi, M.
Sethna, F.
Henry, T.
Chung, E.
Traverse, J.
Chen, Y.
Ozkan, T.
Webb, S.
Miittal, M.
Ervin, L.
Sadek, H.
Mikhail, S.
Haghighi, K.
Samulski, R. J.
Kranias, E. G.
Tretiakova, A.
Hajjar, R. J.
HUMAN GENE THERAPY, 2024, 35 (3-4) : A53 - A53
[4] Safety and Efficacy of Semaglutide Therapy in Advanced Heart Failure Patients Awaiting Heart Transplantation
Poglajen, G.
Frljak, S.
Zemljic, G.
Cerar, A.
Knezevic, I.
Vrtovec, B.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S503 - S503
[5] Efficacy and Safety of Empagliflozin in Hospitalized Heart Failure Patients: Main Results From the EMPULSE Trial
Voors, Adriaan A.
Angermann, Christiane E.
Teerlink, John R.
Collins, Sean P.
Kosiborod, Mikhail N.
Biegus, Jan
Ferreira, Joao P.
Nassif, Michael E.
Psotka, Mitchell A.
Tromp, Jasper
Brueckmann, Martina
Blatchford, Jon
Salsali, Afshin
Ponikowski, Piotr
CIRCULATION, 2021, 144 (25) : E572 - E572
[6] SAFETY AND EFFICACY RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF OCU400 MODIFIER GENE THERAPY FOR TREATMENT OF RETINITIS PIGMENTOSA
Upadhyay, A. K.
Qamar, H.
Matloob, S.
Chavali, M.
CYTOTHERAPY, 2024, 26 (06) : S18 - S18
[7] Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1 : Results from a Phase III Clinical Trial
Saland, Jeffrey M.
Lieske, John C.
Groothoff, Jaap W.
Frishberg, Yaacov
Shasha-Lavsky, Hadas
Magen, Daniella
Moochhala, Shabbir H.
Simkova, Eva
Coenen, Martin
Hayes, Wesley
Hogan, Julien
Sellier-Leclerc, Anne-Laure
Willey, Richard
Gansner, John M.
Hulton, Sally -Anne
KIDNEY INTERNATIONAL REPORTS, 2024, 9 (07): : 2037 - 2046
[8] Phase I, heart failure clinical trial to evaluate the safety of SG1002-A novel hydrogen sulfide donor
Gojon, Gabriel, Sr.
Gojon, Gabriel, Jr.
Lefer, David J.
Elrod, John W.
Giordano, Tony
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2014, 39 : S6 - S7
[9] Efficacy and safety results of FGFR1-3 inhibitor, tinengotinib, as monotherapy in patients with advanced, metastatic cholangiocarcinoma: Results from phase II clinical trial.
Javle, Milind M.
Mahipal, Amit
Fonkoua, Lionel Aurelien Kankeu
Fountzilas, Christos
Li, Daneng
Pelster, Meredith
Liao, Chih-Yi
Richards, Donald A.
Deming, Dustin A.
Younes, Mohamad Ahmad
Mantry, Parvez
Cohn, Allen Lee
Kingsley, Ed
Fan, Jean
Peng, Peng
Sun, Caixia
Wang, Hui
Hennessy, Katie
Shan, Yujun
Wu, Frank
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 434 - 434
[10] Efficacy and safety of gene therapy in patients with advanced coronary heart disease and no options for revascularization)
Stewart, DJ
REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (01): : 89 - 98

← 1 2 3 4 5 →